Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Supaglutide

A Study of Supaglutide in Chinese Type 2 Diabetes Patients

Shanghai Yinnuo Pharmaceutical Technology Co. · Phase 2 · Completed · Enrollment 40

NCT04314622

ArmNauseaVomitingDiarrheaDiscontinuationDeaths
Supaglutide (Part A)n/rn/rn/rn/rn/r
Placebo(Part A)n/rn/rn/rn/rn/r
Supaglutide (Part B)n/rn/rn/rn/rn/r
Placebo (Part B)n/rn/rn/rn/rn/r

A count stays a count. This page does not turn a count into a percent.